Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Dario Freitas likes this,Join us at ESC2024 for 3D echo w...
View:
Post by jopatclo on Aug 22, 2024 7:33am

Dario Freitas likes this,Join us at ESC2024 for 3D echo w...

Interesting see = with all existing ultrasound machines post Dear Friend; in point 3. = c. (c. instantaneous calibration with all existing ultrasound machines, which makes the user experience seamless with the normal cardiac imaging procedure;) Dear Friend;
 
Attached is today’s news release announcing the approval for sale of the latest VMS+ model.  Here is some background:
 
1. The VMS+3.0 is our base version which we have been providing to major hospitals in Canada, Europe and USA and we will continue to provide it as a base model.
2. The VMS+4.0 will be a premium model sold at a premium price, as it does so much more.
3. The more is:
a.  broader applicability to all cardiac patients, even those with pacemakers and defibrillators who cannot go into an MRI and so the ability of clinicians to properly assess their hearts has been limited. This is an engineering breakthrough as up to now, the use of the VMS+ in such patients has been a restriction on its use - not any more;  
b.  automated analysis, which speeds up the analysis process and also provides even more reliability by eliminating operator-operator variability;
c.  instantaneous calibration with all existing ultrasound machines, which makes the user experience seamless with the normal cardiac imaging procedure;
d.  better 3D visualization of the whole beating heart, which allows the cardiologist to explain to patients exactly how the heart is misfiring and how it can be treated;
e.  new detailed measurements of heart function, which allows the clinician to focus in on one chamber of the heart or even one area of the heart and measure its movement and ability to contract.
4. The Company has applied to US-FDA for clearance of the VMS+4.0 in the USA and we a finalizing an application for CE Mark for European approval.
5. The Company will now offer upgrades to its existing customers in Canada as well as marketing it to new hospitals and imaging centers.
 
Thank you for your interest and support as we continue to improve cardiac diagnostics for everyone, everywhere, and especially for children born with a heart defect.
 
Regards,
 
Dr. George Adams ICD.D
Join us at hashtagESC2024 for 3D echo workshops in Congenital Heart Disease. Interesting cases, new tech and friendly experts!!
hashtagCHD hashtag3DEcho hashtagEchocardiography

John Simpson

DE WET NEL

Sueli Gomes
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities